- Home
- PRPO vs MNDO Comparison
PRPO vs MNDO Comparison
Compare PRPO & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- MNDO
- Stock Information
- Founded
- PRPO N/A
- MNDO 1995
- Country
- PRPO United States
- MNDO Israel
- Employees
- PRPO N/A
- MNDO N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- MNDO EDP Services
- Sector
- PRPO Industrials
- MNDO Technology
- Exchange
- PRPO Nasdaq
- MNDO Nasdaq
- Market Cap
- PRPO 22.0M
- MNDO 24.2M
- IPO Year
- PRPO N/A
- MNDO 2000
- Fundamental
- Price
- PRPO $15.41
- MNDO $1.20
- Analyst Decision
- PRPO
- MNDO
- Analyst Count
- PRPO 0
- MNDO 0
- Target Price
- PRPO N/A
- MNDO N/A
- AVG Volume (30 Days)
- PRPO 10.3K
- MNDO 59.4K
- Earning Date
- PRPO 08-13-2025
- MNDO 08-11-2025
- Dividend Yield
- PRPO N/A
- MNDO 18.18%
- EPS Growth
- PRPO N/A
- MNDO N/A
- EPS
- PRPO N/A
- MNDO 0.15
- Revenue
- PRPO $21,242,000.00
- MNDO $20,155,000.00
- Revenue This Year
- PRPO N/A
- MNDO N/A
- Revenue Next Year
- PRPO N/A
- MNDO N/A
- P/E Ratio
- PRPO N/A
- MNDO $8.00
- Revenue Growth
- PRPO 27.05
- MNDO N/A
- 52 Week Low
- PRPO $3.90
- MNDO $1.02
- 52 Week High
- PRPO $16.89
- MNDO $2.13
- Technical
- Relative Strength Index (RSI)
- PRPO 69.89
- MNDO 43.61
- Support Level
- PRPO $14.04
- MNDO $1.10
- Resistance Level
- PRPO $16.27
- MNDO $1.20
- Average True Range (ATR)
- PRPO 0.64
- MNDO 0.06
- MACD
- PRPO 0.10
- MNDO 0.01
- Stochastic Oscillator
- PRPO 84.48
- MNDO 72.00
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.